Internal Medicine, Gastroenterology · Nashville, TN
NPI
1770921553
Since 2013
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 the Vanderbilt Clinic
Nashville, TN, 37232
Phone (615) 322-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
402 services
Medicare patients, 2024
187
Average age 69
Drug cost, 2024
$4.6M
727 prescriptions
Company payments, 2025
$27K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Baldeep S Pabla was code 45385 (colonoscopy - lesion removal), 77 times for 76 patients. In total Baldeep S Pabla billed 402 services in 35 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Office | 77 | 76 | $176.36 | $14K |
| 45380 Lower GI Endoscopy - Other | Office | 66 | 65 | $56.48 | $3,728 |
| 99214 Office E&M - Established | Office | 42 | 30 | $69.61 | $2,924 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 30 | 22 | $12.17 | $365 |
| 99215 Office E&M - Established | Office | 23 | 18 | $90.52 | $2,082 |
| 99213 Office E&M - Established | Office | 21 | 21 | $52.03 | $1,093 |
| 99222 Hospital E&M - Initial | Facility | 17 | 17 | $89.86 | $1,528 |
| 43239 Upper GI Endoscopy | Office | 17 | 17 | $58.02 | $986 |
By year: 2022 $28K for 274 services; 2023 $30K for 307 services; 2024 $34K for 402 services.
Medicare prescription drug claims, 2024
In 2024, the drug Baldeep S Pabla prescribed most often to Medicare patients was Rinvoq (Upadacitinib), with 95 prescriptions and refills. In total Baldeep S Pabla wrote 727 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rinvoq Upadacitinib | 95 | 95 | 12 | $717K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 89 | 89 | 89 | $1,272 |
| Stelara Ustekinumab | 80 | 128 | 15 | $2.2M |
| Humira(Cf) Pen Adalimumab | 40 | 40 | Under 11 | $487K |
| Skyrizi On-Body Risankizumab-Rzaa | 35 | 63 | Under 11 | $669K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 30 | 30 | 29 | $427 |
| Mesalamine Generic | 27 | 67 | Under 11 | $14K |
| Azathioprine Generic | 27 | 35 | Under 11 | $962 |
| Omvoh Pen Mirikizumab-Mrkz | 22 | 22 | Under 11 | $210K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 20 | 20 | 19 | $344 |
| Balsalazide Disodium Generic | 18 | 18 | Under 11 | $1,838 |
| Pantoprazole Sodium Generic | 16 | 34 | Under 11 | $254 |
| Mesalamine Er Mesalamine | 15 | 15 | Under 11 | $1,030 |
| Budesonide Generic | 14 | 14 | Under 11 | $8,391 |
| Methotrexate Methotrexate Sodium | 14 | 18 | Under 11 | $147 |
Brand drugs: 371 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Baldeep S Pabla $27K ($27K in general payments such as food, travel and fees) from 9 companies. The largest payer was Lilly USA, LLC with $26K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.